- Home
- LNZA vs MYO Comparison
LNZA vs MYO Comparison
Compare LNZA & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- MYO
- Stock Information
- Founded
- LNZA 2005
- MYO 2004
- Country
- LNZA United States
- MYO United States
- Employees
- LNZA N/A
- MYO N/A
- Industry
- LNZA Major Chemicals
- MYO Industrial Specialties
- Sector
- LNZA Industrials
- MYO Health Care
- Exchange
- LNZA Nasdaq
- MYO Nasdaq
- Market Cap
- LNZA 199.8M
- MYO 178.4M
- IPO Year
- LNZA N/A
- MYO 2017
- Fundamental
- Price
- LNZA $0.20
- MYO $4.30
- Analyst Decision
- LNZA Hold
- MYO Strong Buy
- Analyst Count
- LNZA 2
- MYO 4
- Target Price
- LNZA $2.00
- MYO $9.75
- AVG Volume (30 Days)
- LNZA 4.4M
- MYO 625.9K
- Earning Date
- LNZA 05-08-2025
- MYO 03-10-2025
- Dividend Yield
- LNZA N/A
- MYO N/A
- EPS Growth
- LNZA N/A
- MYO N/A
- EPS
- LNZA N/A
- MYO N/A
- Revenue
- LNZA $58,025,000.00
- MYO $32,551,198.00
- Revenue This Year
- LNZA N/A
- MYO $32.15
- Revenue Next Year
- LNZA $77.26
- MYO $17.59
- P/E Ratio
- LNZA N/A
- MYO N/A
- Revenue Growth
- LNZA 7.99
- MYO 69.17
- 52 Week Low
- LNZA $0.20
- MYO $2.51
- 52 Week High
- LNZA $3.41
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- LNZA 26.07
- MYO 35.57
- Support Level
- LNZA $0.22
- MYO $4.57
- Resistance Level
- LNZA $0.33
- MYO $5.04
- Average True Range (ATR)
- LNZA 0.06
- MYO 0.24
- MACD
- LNZA -0.00
- MYO -0.05
- Stochastic Oscillator
- LNZA 10.76
- MYO 10.58
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).